Literature DB >> 21857861

Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome.

F O Okogbo1, O C Ezechi, O M Loto, P M Ezeobi.   

Abstract

BACKGROUND: Uterine leiomyoma is remarkably common, however only a subset of women have their fibroids clinically detected, symptomatic, or warrant surgical treatment. Its removal is commonly associated with complications. To prevent or control the occurrence of this complication requires the understanding of the factors associated with the complications.
OBJECTIVE: To evaluate the sociodemographic, clinical characteristics, management outcome and its determinants in southwestern Nigeria.
METHODS: Study was carried out at two large tertiary hospitals in the south west region of Nigeria. Retrospective review of case records of all surgically managed cases of uterine leiomyoma over a period of 25 years. One hundred and fifty nine women with uterine leiomyoma seen and managed surgically in South-Western Nigeria were the participants.
RESULTS: The common presenting complaints were menstrual irregularities (47.7%), abdominal swelling (39.1%) and infertility (31.9%). The average uterine size at presentation was 15±9.7 weeks. The majority (79.9%) of the women presented with multiple leiomyomata. The commonest anatomical position of the nodules were multiple positions and intramural in 707(60.9%) and 172(14.8%) respectively. Myomectomy was performed in 54.7% of cases. Postoperative complications occurred in 20.9 % of cases with postoperative pyrexia (13.5%), blood loss warranting transfusion (12.8%) and postoperative anaemia (10.4%) been the most common complications.
CONCLUSION: Uterine fibroid is common in our environment and its removal is commonly associated with post-operative pyrexia, blood loss, and anaemia and wound infection. Midline incision, closure of rectus sheet with chromic catgut and myomectomy were associated with postoperative complications in this review.

Entities:  

Keywords:  Leiomyomata; Uterine fibroid

Mesh:

Year:  2011        PMID: 21857861      PMCID: PMC3158515     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  16 in total

Review 1.  Fibroids and in-vitro fertilization: which comes first?

Authors:  Beth W Rackow; Aydin Arici
Journal:  Curr Opin Obstet Gynecol       Date:  2005-06       Impact factor: 1.927

Review 2.  Uterine fibroids: a clinical review.

Authors:  B J Vollenhoven; A S Lawrence; D L Healy
Journal:  Br J Obstet Gynaecol       Date:  1990-04

3.  Myomectomy in infertile Jamaican women.

Authors:  B S Sengupta; H H Wynter; L Matadial; A Halfen
Journal:  Int J Gynaecol Obstet       Date:  1978       Impact factor: 3.561

4.  Hysterectomy in the Hausa/Fulani population in Nigeria.

Authors:  B U Ezem; J A Otubu
Journal:  Int J Gynaecol Obstet       Date:  1981-04       Impact factor: 3.561

5.  Uterine fibromyomata: presentation and management in northern Nigeria.

Authors:  J O Emembolu
Journal:  Int J Gynaecol Obstet       Date:  1987-10       Impact factor: 3.561

6.  Myomectomy: a reappraisal and post-operative reproductive performance.

Authors:  A E Omu; A Ehigiegba
Journal:  Asia Oceania J Obstet Gynaecol       Date:  1983-03

Review 7.  Fibroids in pregnancy--common but poorly understood.

Authors:  Natalie Paloma Cooper; Stanley Okolo
Journal:  Obstet Gynecol Surv       Date:  2005-02       Impact factor: 2.347

Review 8.  Fibroids, infertility and pregnancy wastage.

Authors:  N Bajekal; T C Li
Journal:  Hum Reprod Update       Date:  2000 Nov-Dec       Impact factor: 15.610

9.  Management of uterine fibroids at the University of Benin Teaching Hospital.

Authors:  A E Omu; I J Ihejerika; G Tabowei
Journal:  Trop Doct       Date:  1984-04       Impact factor: 0.731

10.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

View more
  8 in total

1.  Abdominal myomectomy: A retrospective review of determinants and outcomes of complications at the University of Ilorin Teaching Hospital, Ilorin, Nigeria.

Authors:  Kikelomo T Adesina; Beatrice O Owolabi; Hadijat O Raji; Adebunmi O Olarinoye
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

2.  IGF-1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolization.

Authors:  Yongxu Mu; Junfeng He; Ruiqiang Yan; Xiaoyan Hu; Haiyan Liu; Zhiming Hao
Journal:  Exp Ther Med       Date:  2015-12-08       Impact factor: 2.447

3.  Successful pregnancy following myomectomy for giant uterine fibroid in an infertile woman.

Authors:  Euzebus Chinonye Ezugwu; Chukwuemeka Anthony Iyoke; Frank Okechukwu Ezugwu; George Ugwu
Journal:  J Reprod Infertil       Date:  2014-10

4.  Providing medical care in unfamiliar settings; experience of an Egyptian campaign in Uganda.

Authors:  Ahmed Hasanin; Nadine Sherif; Mohamed Elbarbary; Doaa Mansor
Journal:  Pan Afr Med J       Date:  2014-02-14

5.  Burden of Uterine Fibroids: An African Perspective, A Call for Action and Opportunity for Intervention.

Authors:  P Igboeli; W Walker; A McHugh; A Sultan; A Al-Hendy
Journal:  Curr Opin Gynecol Obstet       Date:  2019-08-11

6.  Outcomes of Myomectomy at the Time of Cesarean Section among Pregnant Women with Uterine Fibroids: A Retrospective Cohort Study.

Authors:  Rong Zhao; Xin Wang; Liying Zou; Weiyuan Zhang
Journal:  Biomed Res Int       Date:  2019-03-10       Impact factor: 3.411

7.  Infertility and associated factors in three hospitals in Douala, Cameroon: a cross-sectional study.

Authors:  Thomas Obinchemti Egbe; Charmaine Ngo Mbaki; Nicholas Tendongfor; Elvis Temfack; Eugene Belley-Priso
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

8.  [Epidemiological profile of uterine fibroids in the region of Sidi Bel Abbes, Algeria].

Authors:  Nourelhouda Chalal; Abbassia Demmouche
Journal:  Pan Afr Med J       Date:  2013-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.